5th CBD Symposium
October 16 @ 8:00 am - October 17 @ 11:00 am
Business is good for CBD with 2018 expected to surpass $560Mil in North American sales. However, planning for the next major push into consumer and patient growth for CBD– in its’ many delivery forms — will prove the next two years are critical. Will you be ready? How will the 2018 US Farm Bill interact with the ability for domestic farmers to fully enter the market? How will GW Pharma’s entry with their FDA-approved Epidiolex scramble consumer choices? Is clinical research and product innovation able to expand the consumer demand curve? Hear from 22 global experts on 9 panels and solo presentations. And as always, you take home the 90-file CBOutlook DataDisk of leading academic research.